|
|
Transcripts that showed significantly increased expression in rrf-3(pk1426) comparing to in N2 at L3 larva stage. |
DESeq2v 1.18.1, fold change > 1.5, adjusted p-value < 0.01. |
WBPaper00056169:rrf-3(pk1426)_upregulated_L3
|
|
|
Transcripts that showed significantly increased expression in hda-1(RNAi) embryos comparing to control animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00067044:hda-1(RNAi)_upregulated
|
|
|
Transcripts that showed significantly decreased expression in eat-2(ad1116) comparing to in N2 at 3-days post L4 adult hermaphrodite animals. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:eat-2(ad1116)_downregulated
|
|
|
Transcripts that showed significantly increased expression in dpy-21(e428) comparing to in N2 during L3 stage. |
DESeq v1.6.3. Fold change > 1.5. |
WBPaper00050370:dpy-21(e428)_L3_upregulated
|
|
|
Transcripts that showed significantly decreased expression after animals were treated with 50uM Rifampicin and 250uM Allantoin from day 1 to day 3 adult hermaphradite. |
DESeq2(v1.14.1), fold change > 2, p-value < 0.05 |
WBPaper00055354:Rifampicin-Allantoin_downregulated
|
|
|
Transcripts that showed significantly decreased expression in whole animal day 1 N2 adults comparing to in whole animal day 8 N2 adults. |
DESeq2, FDR < 0.05, fold change > 2. |
WBPaper00066978:Day1Adult_vs_Day8Adult_downregulated_neuron
|
|
|
Transcripts that showed significantly increased expression in spr-1(ok2144) comparing to in N2. |
DESeq2, fold change > 2, p-value < 0.01. |
WBPaper00061203:spr-1(ok2144)_upregulated
|
|
|
Transcripts that showed significantly increased expression in xpf-1(tm2842) comparing to in N2 animals. |
DESeq2 1.14.1, fold change > 2, FDR < 0.01. |
WBPaper00062497:xpf-1(tm2842)_upregulated
|
|
Bacteria: Pseudomonas donghuensis HYS |
Transcripts that showed significantly increased expression after 24 hours of infection by Pseudomonas donghuensis HYS, comparing to control animals exposed to OP50. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00068216:HYS_vs_OP50_upregulated
|
|
|
Transcripts that showed significantly decreased expression in numr-1/2(RNAi) animals treated with 300uM CdCl2 from L1 to late L3 larva stage, comparing to control RNAi animals with the same Cadmium treatment. |
DESeq2, v1.12.0, fold change > 2, FDR < 0.05 |
WBPaper00057068:numr-1(RNAi)_downregulated_Cadmium
|
|
|
Transcripts that showed significantly increased expression in alg-1(gk204) comparing to in N2 at 5-days post L4 adult hermaphrodites. |
DESeq, fold change > 2, adjusted p-value < 0.05. |
WBPaper00054758:alg-1(gk204)_upregulated
|
|
|
Transcripts that showed more than 4 fold of expression in N2 comparing to in CB4856 animals. |
DESeq2, fold change > 4. |
WBPaper00053909:N2_vs_CB4856_upregulated
|
|
|
Transcripts that showed significantly increased expression in lin-53(RNAi) embryos comparing to control animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00067044:lin-53(RNAi)_upregulated
|
|
|
Genes that showed significantly decreased expression in rpn-10(ok1865) comparing to in N2 animals |
Differentially expressed genes were then identified through the use of serial t-testing coupled with Benjamini-Hochberg correction and genes with an adjusted p-value score less than 0.05 were considered to be differentially expressed. |
WBPaper00049177:rpn-10(ok1865)_downregulated
|
|
|
Targets of endo-siRNA that showed significantly increased expression in BFF39[pptr-1(tm3103);Pmex-5::gfp::h2b::tbb-2 (mjIs134 II)] comparing to in SX1263[Pmex-5::gfp::h2b::tbb-2 (mjIs134 II)] dissected gonad isolated from 1-day old adult hermaphrodites. |
DESeq2, fold change > 2, FDR < 0.01 |
WBPaper00057140:pptr-1(tm3103)_upregulated
|
|
|
Transcripts that showed significantly decreased expression in hlh-26(ok1453) animals exposed to E. faecium for 8 hours, comparing to N2 animals exposed to E. faecium for 8 hours. |
Fold change > 2. |
WBPaper00062585:hlh-26(ok1453)_downregulated_E.faecium
|
|
|
Transcripts that showed significantly decreased expression after animals were exposed to 500 uM of 3-dihydro-2-phenyl-sulfanylenebenzo[d] [1,3,2]-oxazaphosphole (FW1256) from L1 stage larvae onwards. |
The DESeq2 package (v1.24.0) was used to identify differentially expressed genes (DEGs). Fold change > 2, FDR < 0.05. |
WBPaper00061040:FW1256_downregulated
|
|
|
Transcripts that showed significantly increased expression in rrf-3(pk1426) comparing to in N2 at L2 larva stage. |
DESeq2v 1.18.1, fold change > 1.5, adjusted p-value < 0.01. |
WBPaper00056169:rrf-3(pk1426)_upregulated_L2
|
|
|
Transcripts that showed significantly increased expression (fold change > 2, adjusted p-value < 0.05) in EKM99[met-2(n4256) set-25(n5021)] injected with vector RNAi, comparing to in control animals (N2 injected with vector RNAi). |
Differential expression analysis was performed using DESeq2 v1.6.3 in R version 3.2.3. All analyses were performed with genes that had average expression level above 1 RPKM (fragments per kilobase per million, as calculated by Cufflinks). |
WBPaper00050193:met-2(n4256)set-25(n5021)_upregulated_L1
|
|
|
Transcripts of noncoding genes that showed significantly decreased expression in muscle. |
DESeq2 (version 1.24.0). Transcripts with a false-discovery rate adjusted p-value less than 0.05 were considered significantly differentially expressed. |
WBPaper00062325:muscle_depleted_noncoding-RNA
|
|
|
Transcripts that showed significantly increased expression (fold change > 2, adjusted p-value < 0.05) in lsm-1(tm3585) injected with vector RNAi, comparing to in control animals (N2 injected with vector RNAi). |
Differential expression analysis was performed using DESeq2 v1.6.3 in R version 3.2.3. All analyses were performed with genes that had average expression level above 1 RPKM (fragments per kilobase per million, as calculated by Cufflinks). |
WBPaper00050193:lsm-1(tm3585)_upregulated_L3
|
